ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
0
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
5,272
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
O-26. The effects of Faslodex and Tamoxifen in premenopausal breast cancer
Publication date
Created:
September 2005
Publication date
(Print):
September 2005
Journal:
European Journal of Cancer Supplements
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Revista Izquierdas
Author and article information
Journal
Title:
European Journal of Cancer Supplements
Abbreviated Title:
European Journal of Cancer Supplements
Publisher:
Elsevier BV
ISSN (Print):
13596349
Publication date Created:
September 2005
Publication date (Print):
September 2005
Volume
: 3
Issue
: 1
Page
: 9
Article
DOI:
10.1016/S1359-6349(05)80026-6
SO-VID:
b47f567f-6427-4f08-9234-657bf0f517a1
Copyright ©
© 2005
License:
https://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
5,272
PCN52 ECONOMIC EVALUATION OF FULVESTRANT (FASLODEX,) AS AN ADDITIONAL ENDOCRINE STEP IN THE TREATMENT SEQUENCE FOR HORMONE-RECEPTOR POSITIVE ADVANCED AND METASTATIC BREAST CANCER IN ISRAEL
Authors:
D. Greenberg
,
M. Rabinovich
,
M. Hirsch
Fulvestrant (‘Faslodex’) demonstrates clinical benefit in heavily pre-treated patients with metastatic breast cancer
Authors:
G Steger
,
R Bartsch
,
C Wenzel
…
Effects of ICI182780 (Faslodex) on proliferation and apoptosis induced by 17β-estradiol in endometrial carcinoma cells.
Authors:
R. X. Guo
,
L. Wei
,
D Zhao
…
See all similar